Effectiveness of Breast Self-Examination (BSE) for Early Detection of Breast Cancer in India (2010–2024)

Background: Breast cancer is the most common cancer among Indian women, with incidence rising and over 90,000 deaths annually. Late-stage presentation is common due to limited screening programs, low awareness and sociocultural barriers. Breast self-examination (BSE) is a low-cost strategy intended to increase women’s breast awareness, but its impact on cancer outcomes in India is unclear. Aim: To systematically review and appraise the evidence on the effectiveness of BSE for early breast cancer detection in India (2010–2024), including Indian and global data, barriers to BSE uptake and recommendations for public health practice. Methods: We conducted a PRISMA-guided literature search (PubMed, Google Scholar, etc.) for studies published 2010–2024 on BSE in India. Search terms included “breast self-examination”, “breast cancer screening”, and “India”. Peer-reviewed studies (randomized, observational, cross-sectional, and interventional) and key reports (WHO/ICMR/NCRP) were included; editorials were used for context. Two reviewers screened titles/abstracts, assessed full texts, and extracted data. In total, ~250 records were identified; after duplicate removal and screening, ~15–20 studies met inclusion criteria (Indian studies of awareness/interventions, plus major global trials). Results: Among included Indian studies, community surveys consistently found very low BSE awareness and practice. For example, only 18% of urban Jaipur women knew about BSE and just 5.7% practiced it. In rural Tamil Nadu, 58% of women had poor BSE knowledge and 89.6% never practiced it. Educational interventions markedly improved uptake: a Mumbai study raised monthly BSE practice from ~3% to 65% after a health-education program. In Hyderabad camps, training ~5,000 women achieved 93% compliance with BSE; 165 new lumps were found, of which 76 (1.5%) were malignant. Suresh et al. trained 7,214 rural women and reported a 1.9% cancer detection rate (142 cases) after augmented BSE (aBSE) plus BSE instruction. By contrast, large international trials (China, Russia) showed no breast-cancer mortality benefit from regular BSE, but nearly doubled false-positive biopsies. In India, no analogous large trial exists, so mortality impact is unknown. Barriers identified include cultural stigma (shyness, fear of a cancer diagnosis) and lack of health education, plus socioeconomic and access issues (low literacy, scarce female providers). Conclusion: Global evidence indicates that BSE alone does not reduce breast cancer mortality, and Indian studies do not contradict this (no mortality data is available). However, Indian experience shows BSE education can raise awareness, increase detection of early lumps, and potentially downstage disease when linked with clinical follow-up. We recommend integrating BSE instruction into community health programs and combining it with clinical breast examination (CBE) by trained providers, to maximize early detection in resource-limited settings. Overcoming cultural and access barriers (through female health workers, school programs, media campaigns) is essential for success. Future research should evaluate structured BSE promotion alongside clinical screening to clarify its impact on early diagnosis and outcomes in India. Keywords: Breast cancer, breast self-examination, early detection, India, systematic review, awareness, screening.